Browsing by Author "e46f285d-c362-473b-a13e-04f5e6ce108b"

Now showing items 1-2 of 2

    • Durability of efavirenz compared with boosted protease inhibitor based regimens in antiretroviral naive ... 
      Caro Vega, Yanink; Belaunzaran Zamudio, Pablo F.; Crabtree Ramírez, Brenda E.; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Gotuzzo, Eduardo; McGowan, Catherine C.; Sierra Madero, Juan G. (Oxford University Press, 2018)
      Background. Efavirenz (EFV) and boosted protease inhibitors (bPIs) are still the preferred options for firstline antiretroviral regimens (firstline ART) in Latin America and have comparable short-term efficacy. We assessed ...
    • The Population Impact of Late Presentation with Advanced HIV Disease and Delayed Antiretroviral Therapy in ... 
      Belaunzarán-Zamudio, Pablo F.; Caro Vega, Yanink N.; Shepherd, Bryan E.; Rebeiro, Peter F.; Crabtree-Ramírez, Brenda E.; Cortés, Claudia P.; Grinsztejn, Beatriz; Gotuzzo, Eduardo; Mejía, Fernando; Padgett, Denis; Pape, Jean W.; Rouzier, Vanessa; Veloso, Valdilea G.; Wagner Cardoso, Sandra; McGowan, Catherine C.; Sierra Madero, Juan G. (Oxford University Press, 2020)
      Late presentation to care and antiretroviral therapy (ART) initiation with advanced HIV-disease are common in Latin America. We estimated the impact of these conditions on mortality in the region. We included adults ...